Biochemical and Biophysical Research Communications
Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells
Research highlights
► Ghrelin decreases prostate carcinoma PC-3 cells proliferation. ► Ghrelin favors apoptosis in PC-3 cells. ► Ghrelin increase in intracellular free Ca2+ levels in PC-3 cells. ► Grelin up-regulates expression of T-type Ca2+ channels in PC-3 cells. ► PC-3 cells express T-channels of the CaV3.1 and CaV3.2 subtype.
Introduction
Ghrelin is a 28-amino acid peptide with an n-octanoylation indispensable for its biologic activity originally isolated from the stomach as the endogenous ligand for the growth hormone secretagogue receptor (GSH-R) [1], [2]. Ghrelin is essentially a multifunctional hormone with roles in growth hormone release, food intake and cell proliferation [2], [3]. However, in spite of its widespread and important physiologic actions, its precise regulatory mechanisms remain ambiguous.
The role of ghrelin in the control of cell proliferation and cancer has received considerable attention [3]; however, discordant results have been reported. Hence, proliferative actions of the hormone (or its synthetic analogs) have been observed in hepatoma HepG2 cells, as well as in prostate and breast cancer cell lines [4], [5], whereas antiproliferative effects have been reported in non-tumoral thyroid cell lines, as well as in lung, breast and prostate cancer cell lines [6], [7], [8], [9]. Although the reason for such discrepancy is unknown, possible explanations could include differences in the methodological approaches, in the cell types investigated and/or the expression of GHS-Rs.
Ghrelin and the GHS-R1a are both present in the prostate [4], [10]. However, modified prostatic epithelial cells (both hyperplastic or neoplastic) express higher levels of ghrelin than normal prostate, suggesting the possible existence of an autocrine/paracrine role of the hormone in the neoplastic processes [8], [10]. More specifically, in the androgen-independent human prostate carcinoma PC-3 cells, Jeffery and her colleagues reported that ghrelin at nM concentrations stimulated cell proliferation [4], [10]. In contrast, Cassoni et al. demonstrated that ghrelin had a biphasic effect on the growth of PC-3 cells [8], with a stimulating activity at low concentrations (10–100 pM) and an inhibiting effect at higher doses (1 μM). It is worth noting however that the molecular mechanism underlying the actions of ghrelin on PC-3 cells proliferation remain virtually unexplored. In the present report, we have examined the role exerted by ghrelin on prostatic cancer cells growth in vitro at concentrations quite close to those found in ghrelin-producing tissues (1–50 nM), and further investigated some of the mechanisms by which the hormone was able to inhibit cell proliferation.
Section snippets
Materials
[3H]-Thymidine was obtained from Amersham Life Science; fetal bovine serum was purchased from Invitrogen. Ghrelin (55-0-03A) and GHRP-6 (52-1-80B) were purchased from American Peptide Company Inc. Pimozide (EK-400) was from Alomone Labs and mibefradil was a gift of Dr. J.C. Gómora (Institute of Cellular Physiology, UNAM, Mexico). All other chemicals were reagent grade purchased from Sigma–Aldrich. Plasticware was from Sarstedt.
Cell culture
Human prostate PC-3 cells were a gift of Dr. A. Zentella (National
Results and discussion
As previously described for ghrelin production in prostate cancer, divergent observations have been reported on the GHS-Rs expression in prostate carcinoma cell lines and tissues. Though the presence of GHS-Rs (1a and 1b) at both mRNA and peptide level has been reported in various prostate carcinoma cell lines including PC-3 by Chopin and co-workers [4], [10], neither GHS-R1a mRNA nor protein was detected in the same cells by Cassoni et al. [8]. However, despite the absence of GHS-Rs mRNA, the
Acknowledgments
We thank Drs. J.A. Arias-Montaño (Cinvestav-IPN, Mexico) and J.E. Soria-Jasso (University of Zacatecas, Mexico) for their advise and help in performing the measurements experiments. This work was partially supported by a grant from Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) to R. Felix.
References (21)
- et al.
Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
Trends Endocrinol. Metab.
(2001) - et al.
Ghrelin: a potential therapeutic target for cancer
Regul. Pept.
(2010) - et al.
Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells
J. Biol. Chem.
(2002) - et al.
A new generation of calcium indicators with greatly improved fluorescence properties
J. Biol. Chem.
(1985) - et al.
Ghrelin and GHRP-6 enhance electrical and secretory activity in GC somatotropes
Biochem. Biophys. Res. Commun.
(2007) - et al.
Changes in cytosolic Ca2+ levels regulate Bcl-xS and Bcl-xL expression in spermatogenic cells during apoptotic death
J. Biol. Chem.
(2006) - et al.
L-type Ca2+ channels: a new player in the regulation of Ca2+ signaling, cell activation and cell survival in immune cells
Mol. Immunol.
(2010) - et al.
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Nature
(1999) - et al.
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
J. Endocrinol.
(2002) - et al.
Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue
J. Endocrinol.
(2000)
Cited by (43)
The distinguishing electrical properties of cancer cells
2022, Physics of Life ReviewsGhrelin promotes human non-small cell lung cancer A549 cell proliferation through PI3K/Akt/mTOR/P70S6K and ERK signaling pathways
2018, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Several studies have reported that ghrelin may inhibit cancer cell proliferation. Ghrelin inhibited PC-3 cells proliferation through regulating the expression of T-type Ca(2+) channel [10]. It also reported that ghrelin induced a dose-dependent inhibition on the H345 cell proliferation and increased apoptosis [11].
Ghrelin and cancer progression
2017, Biochimica et Biophysica Acta - Reviews on CancerTargeting calcium signaling in cancer therapy
2017, Acta Pharmaceutica Sinica BGhrelin and its emerging role in tumor pathogenesis and progression
2015, Obesity Research and Clinical PracticeGhrelin augments murine T-cell proliferation by activation of the phosphatidylinositol-3-kinase, extracellular signal-regulated kinase and protein kinase C signaling pathways
2014, FEBS LettersCitation Excerpt :Ghrelin stimulates proliferation of vascular endothelial cells [24], pancreatic β-cells [25], cardiomyocytes [47], adipocytes [41], adrenal cortical cells [48] and prostate cancer cells [45]. On the other hand, ghrelin inhibits the proliferation of aortic smooth muscle cells [49]and human umbilical vein endothelial cells [50]. Interestingly, whereas we found here that ghrelin enhanced the proliferation of peripheral CD4+ murine T cells upon activation with anti-CD3/CD28 mAb and thymic murine T cells upon in vivo ghrelin administration, it has been reported that ghrelin can also inhibit the proliferation of splenic T cells when they are stimulated with anti-CD3 [51].